Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

The study is funded by The Medicines Company by a grant to the University of Oxford. 

Researchers at the Clinical Trials Service Unit, University of Oxford are supported by funding from the British Heart Foundation, the Medical Research Council and Cancer Research UK.